Search

Search Constraints

You searched for: Author/Creator Andrews, J M

Search Results

11. OP24 Clinical efficacy and safety of guselkumab maintenance therapy in patients with moderately to severely active Crohn's Disease: Week 48 analyses from the phase 2 GALAXI 1 study. (21st January 2022)

12. OP28 The effect of guselkumab induction therapy on early clinical outcome measures in patients with Moderately to Severely Active Crohn's Disease: Results from the phase 2 GALAXI 1 study. (27th May 2021)

14. P473 Corticosteroid-free clinical remission rates with guselkumab maintenance therapy in patients with moderately to severely active Crohn's disease: Week 48 analyses from the phase 2 GALAXI 1 study. (30th January 2023)

15. P571 Vedolizumab (VDZ) real-world outcomes in ulcerative colitis (UC). (16th January 2018)

16. P663 Post-ustekinumab induction IL12, IL23, and ustekinumab levels are associated with clinical response in a multi-centre prospective cohort study of Crohn's disease patients: results from the AURORA Study including ANZIBDC Cohort. (30th January 2023)

17. P721 Psychological care is needed and welcomed by patients with inflammatory bowel disease under routine care. (16th January 2018)